Irene Defrancesco

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

Marzia Varettoni, Silvia Zibellini, Irene Defrancesco et al. · Haematologica · 2017 · 118 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Stefano Luminari, Michele Merli, Sara Rattotti et al. · Blood · 2019 · 84 citations · Full text

Medicine, Oncology, Pathology +14

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Sara Rattotti, Virginia Valeria Ferretti, Chiara Rusconi et al. · Hematological Oncology · 2019 · 36 citations

Medicine, Hematology, Infectious Diseases +12

A risk‐stratification model based on the initial concentration of the serum monoclonal protein and <i><scp>MYD</scp>88</i> mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders

Marzia Varettoni, Silvia Zibellini, Emanuela Boveri et al. · British Journal of Haematology · 2019 · 20 citations · Full text

Life Sciences, Immunology, Pathology +8

Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma

Michele Merli, Irene Defrancesco, Carlo Visco et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 20 citations

Medicine, Oncology, Pharmacotherapy +16